Document is current
Any future updates will be listed below
-
Authors
Cotton, Seonaidh
Devereux, Graham http://orcid.org/0000-0002-0024-4887
Abbas, Hassan
Briggs, Andrew
Campbell, Karen
Chaudhuri, Rekha
Choudhury, Gourab
Dawson, Dana
De Soyza, Anthony
Fielding, Shona
Gompertz, Simon
Haughney, John
Lang, Chim C.
Lee, Amanda J.
MacLennan, Graeme
MacNee, William
McCormack, Kirsty
McMeekin, Nicola
Mills, Nicholas L.
Morice, Alyn
Norrie, John
Petrie, Mark C.
Price, David
Short, Philip
Vestbo, Jorgen
Walker, Paul
Wedzicha, Jadwiga
Wilson, Andrew
Lipworth, Brian J.
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (15/130/20)
British Heart Foundation (PG/17/64/33205)
- License Information
-
More Information
Article History
Received: 31 January 2022
Accepted: 26 March 2022
First Online: 14 April 2022
Declarations
:
: The trial has received a favourable opinion from Scotland A Research Ethics Committee (ref CitationRef removed/SS/0033, 22/05/2018) and the Medicines and Healthcare products Regulatory Agency (MHRA) (EudraCT 2017-002779-24, CTA 21583/0222/001-0001, 12/06/2018). All participants provide written informed consent.
: A copy of the participant information leaflet and consent form is available as a InternalRef removed.
: The study is funded by the NIHR Health Technology Assessment. The chief investigator, study grant holders and protocol authors have no financial or competing interests.
